Cognitive Impairment Clinical Trial
Official title:
Intervening to Repair Neuropsychological Deficits in Adult Survivors of Severe Childhood Malnutrition
Globally, in 2011, 52 million children under 5 years old suffered from acute malnutrition,
and a further 165 million children showed evidence of chronic undernutrition or stunting. It
was also estimated that 3.1 million children died in 2011 of malnutrition related causes. The
survivors, due to deprivation of critical nutrients in the most important period of
development and growth, are left with permanent damage, including an increased risk of
cardio-metabolic disease, poorer educational achievement and diminished earning potential.
In Jamaica in 2012, 2.5% of children were moderately or severely underweight (more than two
standard deviations below weight-for-age by international reference populations), falling
from as high as 8.9% in 1993. Though there have been modest reductions in the incidence of
acute malnutrition in Jamaica over the past 20 years, the risk remains high in poor families
and among children who are being weaned. Hence, the problem is an ongoing one and we have a
significant pool of survivors of childhood malnutrition who have now reached adulthood and
face the consequences of early nutrient deprivation.
The brain is particularly vulnerable to the effects of malnutrition and studies have
demonstrated both structural (brain atrophy) and functional (cognitive impairment and poor
academic achievement) changes. This evidence, however, has been mainly in later childhood and
adolescence. In addition, there is local data that suggests that cardio-metabolic risk
factors are increased in these adult survivors, which are well-described precursors of
cerebrovascular disease and cognitive impairment. Therefore, in adulthood there may be
accelerated cognitive decline due to a poor cardio-metabolic profile superimposed on
pre-existing brain injury.
We hypothesise that there are differences in cognitive function (poorer memory and executive
function)and emotional responses in adult survivors of childhood malnutrition compared to
those not exposed to early childhood malnutrition.
There is evidence suggesting that aerobic exercise and omega-3 supplementation have some
benefit in reversing cognitive decline in older adults, but they have not been investigated
in survivors of childhood malnutrition.Hence, we propose to introduce a six month
intervention of supervised aerobic exercise and omega-3 supplementation, and will compare
cognitive function pre and post intervention/placebo between malnutrition survivors and
controls.
This study will assess anthropometry, cardio metabolic profiles, cognitive and emotional
domains between adult survivors of severe acute malnutrition (SAM) in childhood and healthy
controls from similar communities, pre and post a six month intervention of supervised
aerobic exercise and omega-3 supplementation.
Recruitment: The cases will include adult SAM survivors admitted to the University Hospital
of the West Indies (UHWI) now between 20 and 55 years. They have been identified from UHWI
records and traced using last known addresses by experienced field workers. Community
controls will be recruited from the same communities, one per case and matched for sex, and
age (within 5 years).
Sample Size Calculations: These are based on assessing differences in cognitive function
using the NIH (National Institutes of Health) Toolbox Cognitive battery as the primary
outcome measure between SAM survivors and community controls, and between pre-and
post-intervention groups.
Using a test at the 5% level of statistical significance we will have 80% power to detect a
difference of 2.8 √(2/n) standard deviations between cases and controls, where n=number of
cases.
Therefore, at n=50, difference= 2.8 √ (2/50) = 0.56 SD
For the NIH Toolbox, raw scores are converted to a normalized score, where 100 is equivalent
to the normative mean for the relevant age/education stratification, and 15 units corresponds
to 1 standard deviation (SD).
For n=50, 0.56 x 15 = 8.4 units. So, using a test at the 5% level of statistical significance
we will have 80% power to detect a difference of 8.4 units between the two groups.
Meta-analyses on intervention studies of cognitive changes with aerobic exercise have shown a
medium effect size of approximately 0.48-0.57, (154) which corresponds to 7.2-8.5 units.
Hence, using 50 subjects per group will provide an adequate sample size.
Standard Operating Procedures:
After obtaining informed written consent, all baseline data will be collected by one of two
trained researchers over one to two visits. These tests will be repeated after the six-month
intervention.
Details of Methods to be used:
Anthropometry: Height and weight will be measured with subjects without shoes and in light
clothing to calculate body mass index (BMI, kg/m2). Weight will be measured to the nearest
0.1kg. Height will be measured to the nearest 0.1cm.
Dual-energy X-ray absorption (DXA) (Model General Electric Lunar Prodigy) will be used to
measure total and regional percent (%) body fat, fat mass, lean tissue mass, and bone mineral
content.
Blood Pressure: Participants will be rested for >10 minutes seated in a temperature
controlled environment. Blood pressure will be measured three times on the right arm using an
automatic blood pressure monitor with at least 30 seconds in between each reading. The three
measurements will be averaged for analysis. The mid upper arm circumference will be measured
to determine the appropriate sized blood pressure cuff.
Fitness Testing: Subjects will exercise to voluntary exhaustion during a treadmill test using
a modified Bruce protocol. Oxygen consumption, carbon dioxide production, and minute
ventilation will be measured breath-by-breath using a metabolic cart and the average of the
final three 20 second values of oxygen consumption will be the maximum rate of oxygen
consumption.
Cognitive Tests: The NIH Toolbox, a computerised, neurocognitive test battery will be used to
assess cognitive and emotion domains. In the cognitive domain, this study will assess
executive function, cognitive flexibility, inhibitory control, attention, episodic memory,
working memory and processing speed.
For the emotion domain, we will use a self-report battery and test four central subdomains
including psychological well-being, social relationships, stress and self-efficacy and
negative affect.
Blood Tests: 30 millilitres of blood will be taken in the fasted state for assessment of
plasma levels of insulin and glucose, lipids, brain-derived neurotrophic factor, insulin-like
growth factor and omega-3 fatty acid profile in erythrocytes. A full oral glucose tolerance
test will be done with samples for glucose and insulin at 30 minutes, 60 minutes, 90 minutes
and 120 minutes after 75 grams glucose orally.
Data Analysis:
Descriptive data will be provided calculated for all variables. Multiple linear regression
analysis will be used to determine if there are any differences in outcome variables between
survivors and controls. These analyses will be controlled for potential confounding variables
such as age, sex and socio-economic status. The size of effects will be assessed as the
regression coefficient for a binary treatment variable. Change in cognitive outcomes will be
assessed by including the baseline measure of cognitive function as a predictor. Interaction
tests will be used to assess whether any treatment effect differs by baseline cognitive
function, age, sex and socio-economic status.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Recruiting |
NCT04356924 -
Psychological Treatment to Support the Consequences of Cognitive Impairment
|
N/A | |
Suspended |
NCT05542238 -
The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
|
N/A | |
Terminated |
NCT04493957 -
Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT04426838 -
Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad
|
N/A | |
Completed |
NCT04713384 -
Remote Bimanual Virtual Rehabilitation Post CVD
|
N/A | |
Recruiting |
NCT06284213 -
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
|
||
Recruiting |
NCT06053775 -
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)
|
N/A | |
Completed |
NCT03698695 -
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05552729 -
Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT03301402 -
Air Purifier to Improve Endothelial Function and Carotid Intima Thickness
|
N/A | |
Completed |
NCT03187353 -
IMProving Executive Function Study
|
Phase 4 | |
Completed |
NCT05395559 -
Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
|
||
Recruiting |
NCT04907565 -
Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
|
||
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Recruiting |
NCT05030285 -
Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment
|
N/A |